BAYRY

Bayer Aktiengesellschaft | Cotação de Ações

Última atualização24/01/2025, 17:52:40

PreçoUS$ 5,50

Variação (dia)-US$ 0,02 (-0.36%)▼

Min. 52 SemanasUS$ 4,79

Máx. 52 SemanasUS$ 8,84

Capitalização de mercado--

Endereço: Kaiser-Wilhelm-Allee 1, Leverkusen, 51368

Telefone: 49 214 30 1

Funcionários: 96.931

Bayer A.G.BAYRY

US$ 5,50

- 0,020,36%

24/01/2025 17:52:40

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 5,50

Valor de mercado--

AberturaUS$ 5,42

Preço máximoUS$ 5,55

Preço mínimoUS$ 5,48

VolumeUS$ 252 mil

Fechamento anteriorUS$ 5,52

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Ações relacionadas

BASF SE

BASFY ▼0.01% | US$ 11,05

Roche Holding AG

RHHBY ▲0.07% | US$ 35,07

Siemens Aktiengesellschaft

SIEGY ▲0.14% | US$ 98,73

Sanofi

SNY ▲0.30% | US$ 48,73

Novartis AG

NVS ▼0.01% | US$ 98,39

Saiba mais sobre a brapi e nossa missão de fornecer informações confiáveis

Entenda a missão da brapi em fornecer informações estritamente informativas de fontes confiáveis. Valorizamos a transparência e a responsabilidade, incentivando investidores a buscar aconselhamento financeiro independente para decisões informadas.

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.